Hénin E - Search Results

1

Concomitant drugs with low risks of drug-drug interactions for use in oncology clinical trials.

Ranchon F, Vial T, Rioufol C, Hénin E, Falandry C, Freyer G, Trillet-Lenoir V, Le Tourneau C, You B. Ranchon F, et al. Among authors: henin e. Crit Rev Oncol Hematol. 2015 May;94(2):189-200. doi: 10.1016/j.critrevonc.2014.12.014. Epub 2015 Jan 3. Crit Rev Oncol Hematol. 2015. PMID: 25638703 Review.

2

Prediction of tumour response induced by chemotherapy using modelling of CA-125 kinetics in recurrent ovarian cancer patients.

Wilbaux M, Hénin E, Oza A, Colomban O, Pujade-Lauraine E, Freyer G, Tod M, You B. Wilbaux M, et al. Among authors: henin e. Br J Cancer. 2014 Mar 18;110(6):1517-24. doi: 10.1038/bjc.2014.75. Epub 2014 Feb 20. Br J Cancer. 2014. PMID: 24556626 Free PMC article. Clinical Trial.

3

Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs.

Ranchon F, Salles G, Späth HM, Schwiertz V, Vantard N, Parat S, Broussais F, You B, Tartas S, Souquet PJ, Dussart C, Falandry C, Henin E, Freyer G, Rioufol C. Ranchon F, et al. Among authors: henin e. BMC Cancer. 2011 Nov 8;11:478. doi: 10.1186/1471-2407-11-478. BMC Cancer. 2011. PMID: 22067636 Free PMC article.

4

Predictors of prescription errors involving anticancer chemotherapy agents.

Ranchon F, Moch C, You B, Salles G, Schwiertz V, Vantard N, Franchon E, Dussart C, Henin E, Colomban O, Girard P, Freyer G, Rioufol C. Ranchon F, et al. Among authors: henin e. Eur J Cancer. 2012 May;48(8):1192-9. doi: 10.1016/j.ejca.2011.12.031. Epub 2012 Jan 28. Eur J Cancer. 2012. PMID: 22285178

5

Dynamic modeling in ovarian cancer: an original approach linking early changes in modeled longitudinal CA-125 kinetics and survival to help decisions in early drug development.

Wilbaux M, Hénin E, Oza A, Colomban O, Pujade-Lauraine E, Freyer G, Tod M, You B. Wilbaux M, et al. Among authors: henin e. Gynecol Oncol. 2014 Jun;133(3):460-6. doi: 10.1016/j.ygyno.2014.04.003. Epub 2014 Apr 12. Gynecol Oncol. 2014. PMID: 24726614 Clinical Trial.

6

Multiparameter Phase I trials: a tool for model-based development of targeted agent combinations--example of EVESOR trial.

El-Madani M, Hénin E, Lefort T, Tod M, Freyer G, Cassier P, Valette PJ, Rodriguez-Lafrasse C, Berger F, Guitton J, Lachuer J, Slimane K, Barrois C, You B. El-Madani M, et al. Among authors: henin e. Future Oncol. 2015;11(10):1511-8. doi: 10.2217/fon.15.49. Future Oncol. 2015. PMID: 25963428 Clinical Trial.

7

Adherence to oral anticancer chemotherapy: What influences patients' over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methods.

Bourmaud A, Henin E, Tinquaut F, Regnier V, Hamant C, Colomban O, You B, Ranchon F, Guitton J, Girard P, Freyer G, Tod M, Rioufol C, Trillet-Lenoir V, Chauvin F. Bourmaud A, et al. Among authors: henin e. BMC Res Notes. 2015 Jul 4;8:291. doi: 10.1186/s13104-015-1231-8. BMC Res Notes. 2015. PMID: 26142140 Free PMC article.

8

Etoposide pharmacokinetics impact the outcomes of lymphoma patients treated with BEAM regimen and ASCT: a multicenter study of the LYmphoma Study Association (LYSA).

You B, Salles G, Bachy E, Casasnovas O, Tilly H, Ribrag V, Sebban C, Hénin E, Guitton J, Tod M, Freyer G. You B, et al. Among authors: henin e. Cancer Chemother Pharmacol. 2015 Nov;76(5):939-48. doi: 10.1007/s00280-015-2866-9. Epub 2015 Sep 21. Cancer Chemother Pharmacol. 2015. PMID: 26391155

9

Revisiting dosing regimen using PK/PD modeling: the MODEL1 phase I/II trial of docetaxel plus epirubicin in metastatic breast cancer patients.

Hénin E, Meille C, Barbolosi D, You B, Guitton J, Iliadis A, Freyer G. Hénin E, et al. Breast Cancer Res Treat. 2016 Apr;156(2):331-41. doi: 10.1007/s10549-016-3760-9. Epub 2016 Mar 22. Breast Cancer Res Treat. 2016. PMID: 27002506 Clinical Trial.

10

Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences?

Ranchon F, Vantard N, Henin E, Bachy E, Sarkozy C, Karlin L, Bouafia-Sauvy F, Gouraud A, Schwiertz V, Bourbon E, Baudouin A, Caffin AG, Vial T, Salles G, Rioufol C. Ranchon F, et al. Among authors: henin e. Hematol Oncol. 2018 Apr;36(2):399-406. doi: 10.1002/hon.2479. Epub 2017 Oct 6. Hematol Oncol. 2018. PMID: 28983943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page